AbCellera Biologics Inc. ABCL Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Product | ||||||
| Licensing and royalty revenue | $191K+14.4% | —— | —— | —— | $167K— | |
| Research fees | $8.12M+99.7% | $7.68M+61.2% | $8.82M+40.2% | $6.64M+21.7% | $4.07M-58.4% | |
| Accounts Receivable by Geography | ||||||
| CA-BC | $17.72M-17.4% | —— | $17.28M-23.4% | $17.66M-2.3% | $21.45M— | |
| Canada | $12.49M-36.6% | —— | $21.57M+33.4% | $25.69M+106% | $19.68M— | |
| Funding commitment received by Geography | ||||||
| CA-BC | $35.5M-52.7% | —— | $75M0.0% | $75M0.0% | $75M— | |
| Canada | $94.4M— | —— | —— | —— | —— | |
| Accrued grants receivable by Geography | ||||||
| CA-BC | $17.7M— | —— | —— | —— | —— | |
| Canada | $12.5M— | —— | —— | —— | —— | |
| Government Assistance, Liability by Geography | ||||||
| CA-BC | $24.79M-6.2% | —— | $25.64M-4.9% | $26.06M+15.0% | $26.42M— | |
| Canada | $81.15M-3.6% | —— | $81.34M-1.5% | $82.74M+167% | $84.22M— | |
| Government assistance, award amount, undrawn grant funding by Geography | ||||||
| CA-BC | $60.2M— | —— | —— | —— | —— | |
| Canada | $111.8M— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does AbCellera Biologics Inc. break its business down?
- AbCellera Biologics Inc. (ABCL) reports total revenue by product across 2 parts — Licensing and royalty revenue and Research fees. Each is extracted from the segment footnotes and tracked over time.
- Where does AbCellera Biologics Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in AbCellera Biologics Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.